Exact Mass: 388.31298400000003
Exact Mass Matches: 388.31298400000003
Found 189 metabolites which its exact mass value is equals to given mass value 388.31298400000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2alpha-Methyl-17beta-[(tetrahydro-2H-pyran-2-yl)oxy]-5alpha-androstan-3-one
11Z,14Z,17Z,20Z-hexacosatetraenoic acid
3-Hydroxy-1-phenyl-1-eicosanone
3-Hydroxy-1-phenyl-1-eicosanone is found in fats and oils. 3-Hydroxy-1-phenyl-1-eicosanone is a constituent of the pollen of Helianthus annuus (sunflower) Constituent of the pollen of Helianthus annuus (sunflower). 3-Hydroxy-1-phenyl-1-eicosanone is found in fats and oils.
Methyl 2-(10-heptadecenyl)-6-hydroxybenzoate
Methyl 2-(10-heptadecenyl)-6-hydroxybenzoate is found in fats and oils. Methyl 2-(10-heptadecenyl)-6-hydroxybenzoate is isolated from Ginkgo biloba (ginkgo). Isolated from Ginkgo biloba (ginkgo). Methyl 2-(10-heptadecenyl)-6-hydroxybenzoate is found in fats and oils.
Eicosapentaenoylcholine
Eicosapentaenoylcholine, also known as choline eicosapentaenoic acid, belongs to the class of organic compounds known as acyl cholines. These are acylated derivatives of choline. Choline or 2-hydroxy-N,N,N-trimethylethanaminium is a quaternary ammonium salt with the chemical formula (CH3)3N+(CH2)2OH. Eicosapentaenoylcholine has been identified in blood (PMID: 31160086).
17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one
Azacosterol
2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran
MG(18:1(12Z)-2OH(9,10)/0:0/0:0)
MG(18:1(12Z)-2OH(9,10)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/18:1(12Z)-2OH(9,10)/0:0)
MG(0:0/18:1(12Z)-2OH(9,10)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
(2E,6S)- 6-[(1R,3aS,5Z,9R,10Z,12aR)-1,2,3,3a,4,7,8,9,12,12a-Decahydro-9-hydroxy-3a,6,10-trimethyl-1-cyclopentacycloundecenyl]-2-methyl-2-heptenoic acid
18-(3-Methylbutanoyl)----7,15-Pimaradiene-2,18-diol|2alpha-hydroxy-19-isovaleroyl-9-epi-ent-pimara-7,15-diene
8beta-hydroxy-11alpha-tiglinoyloxy-sandaracopimar-15-ene
(5S)-5-hydroxy-((10Z,13Z)-2-oxononadeca-10,13-dienyl)cyclohex-2-enone|(5S)-5-hydroxy-<(10Z,13Z)-2-oxononadeca-10,13-dienyl>cyclohex-2-enone
1-O-acetyl-2-O-[(R)-3-hydroxyhexadecanoyl]-sn-glycerol
4,6,8,10,12,14,16-Heptamethyl-6,8,11-octadecatriene-3,5,13-trione
8beta-hydroxy-11alpha-senecioyloxy-sandaracopimar-15-ene
Dimethyl-10-methoxy-9-hydroxy-octadecan-1,18-dioat
methyl (4R)-4-((5R,9S,10S,12S,13R,17R)-12-hydroxy-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
1α-hydroxy-21-nor-20-oxavitamin D3 / 1α-hydroxy-21-nor-20-oxacholecalciferol
1α,25-dihydroxy-23,24-dinorvitamin D3 / 1α,25-dihydroxy-23,24-dinorcholecalciferol
1α,25-dihydroxy-26,27-dinorvitamin D3 / 1α,25-dihydroxy-26,27-dinorcholecalciferol
(7E)-(1S)-19-nor-9,10-seco-5,7-cholestadiene-1,25-diol
(7E)-(1R)-19-nor-9,10-seco-5,7-cholestadiene-1,25-diol
(7E)-(3R)-19-nor-9,10-seco-5,7-cholestadiene-3,25-diol
25-dihydroxy-19-norvitamin D3 / 25-dihydroxy-19-norcholecalciferol
HU210
ascr#26
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (14R)-14-hydroxypentadecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#26
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 15-hydroxypentadecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
1alpha-hydroxy-21-nor-20-oxavitamin D3 / 1alpha-hydroxy-21-nor-20-oxacholecalciferol
1alpha,25-dihydroxy-23,24-dinorvitamin D3
1alpha,25-dihydroxy-26,27-dinorvitamin D3
3-hydroxy-4R-methyl-2-(n-eicos-11-yn-19-enyl)but-2-enolide
azepan-2-one,hexanedioic acid,2-piperazin-1-ylethanamine
TRANS-1-(4-PENTYLCYCLOHEXYL)-4-(2-(4-PROPOXYPHENYL)ETHYNYL)BENZENE
TRANS,TRANS-4-(4-PROPYLCYCLOHEXYL)-4-(4-ETHYLCYCLOHEXYL)-BIPHENYL
2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran
Tocol, (2R)-
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols
(14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoic acid
15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoic acid
1alpha-hydroxy-21-nor-20-oxavitamin D3/1alpha-hydroxy-21-nor-20-oxacholecalciferol
[(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentyl]-dimethylazanium
[3-Carboxy-2-(3-hydroxytetradecanoyloxy)propyl]-trimethylazanium
C21H42NO5+ (388.30628220000006)
[3-Carboxy-2-(2-hydroxytetradecanoyloxy)propyl]-trimethylazanium
C21H42NO5+ (388.30628220000006)
[3-Carboxy-2-(12-carboxydodecanoyloxy)propyl]-trimethylazanium
N-arachidonoyl-gamma-aminobutyrate
A monocarboxylic acid anion that is the conjugate base of N-arachidonoyl-gamma-aminobutyric acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
methyl (4R)-4-((5R,9S,10S,12S,13R,17R)-12-hydroxy-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
3beta-(2-Diethylaminoethoxy)androst-5-en-17-one cation
[(2R)-3-carboxy-2-(12-carboxydodecanoyloxy)propyl]-trimethylazanium
(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoic acid
17alpha-Hydroxyprogesterone 3,20-bis(O-methyloxime)
2-(Trimethylsilyloxy)tetradecanoic acid trimethylsilyl ester
C20H44O3Si2 (388.28288339999995)
[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
(11Z,14Z,17Z,20Z)-hexacosatetraenoic acid
A very long-chain omega-6 fatty acid that is tetracosanoic acid having four double bonds located at positions 11, 14, 17 and 20 (the 11Z,14Z,17Z,20Z-isomer).
14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl 2-methylbut-2-enoate
[(1r,3as,3br,7s,9ar,9bs,11ar)-7-(dimethylamino)-1-[(1s)-1-(dimethylamino)ethyl]-9a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methanol
methyl 2-methoxy-6-[(8z,13s)-13-methylpentadec-8-en-1-yl]benzoate
(1s,2s,3s,5r,6s,9s,13s,14r,17r,19r)-9-isopropyl-2,6,13,17-tetramethyl-18-oxapentacyclo[15.1.1.0²,¹⁴.0⁵,¹³.0⁶,¹⁰]nonadec-10-ene-3,19-diol
methyl 2-methoxy-6-(13-methylpentadec-8-en-1-yl)benzoate
[(1s,4ar,5s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methyl (2e)-2-methylbut-2-enoate
5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-1,13-diol
(2z)-3-(4-hydroxyphenyl)prop-2-en-1-yl hexadecanoate
(1s,2s)-3-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-1-[(2s)-2-methyloxiran-2-yl]propane-1,2-diol
6-{9-hydroxy-3a,6,10-trimethyl-1h,2h,3h,4h,7h,8h,9h,12h,12ah-cyclopenta[11]annulen-1-yl}-2-methylhept-2-enoic acid
(1r,2r,4s,7s,8s,11s,12r,14s,17r,18s)-1-hydroxy-17-isopropyl-2,7,11,14-tetramethyl-3-oxapentacyclo[10.7.0.0²,⁴.0⁴,⁸.0¹⁴,¹⁸]nonadecan-16-one
(1r,5as,5br,7as,11as,11br,13r,13as,13bs)-5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-1,13-diol
(6e,8e,11e)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11-triene-3,5,13-trione
1-{3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl}-2,4-dihydroxy-4-methylpentan-3-one
(2e,6s)-6-[(1r,3as,9r,12ar)-9-hydroxy-3a,6,10-trimethyl-1h,2h,3h,4h,7h,8h,9h,12h,12ah-cyclopenta[11]annulen-1-yl]-2-methylhept-2-enoic acid
2-ethenyl-10a-hydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 2-methylbut-2-enoate
7-hydroxy-1-(1-hydroxypropan-2-yl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(1r,3ar,5ar,6r,7r,9as,11ar)-7-hydroxy-1-[(2s)-1-hydroxypropan-2-yl]-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(2s)-pentan-2-yl 3-[(1s,2s,3r)-2-[2-(furan-3-yl)ethyl]-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoate
(1r,2r,4s,7s,8s,11r,12r,14s,17r,18s)-1-hydroxy-17-isopropyl-2,7,11,14-tetramethyl-3-oxapentacyclo[10.7.0.0²,⁴.0⁴,⁸.0¹⁴,¹⁸]nonadecan-16-one
(2s,4r,4as,4bs,8as,10ar)-2-ethenyl-10a-hydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl (2e)-2-methylbut-2-enoate
6-(hydroxymethyl)-3-isopropyl-10,16a-dimethyl-14-methylidene-1h,2h,3h,3ah,8h,9h,12h,13h,15h,16h-cyclopenta[15]annulene-2,8-diol
10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecan]-9'-en-14'-ol
6-[(2e,4e,8e,10e)-6,8-dimethylpentadeca-2,4,8,10,14-pentaen-1-yl]-2,3,5-trimethyloxane-2,4-diol
5-(hydroxymethyl)-3-(icosa-11,13-diyn-1-yl)oxolan-2-one
[7-(dimethylamino)-1-[1-(dimethylamino)ethyl]-9a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methanol
(1r,3r,4s,4ar,8ar)-4-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl (2z)-2-methylbut-2-enoate
[(1s,3as,3br,7s,9ar,9bs,11ar)-7-(dimethylamino)-1-[(1r)-1-(dimethylamino)ethyl]-9a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methanol
(1s,4s,6r,9s,10s,13r,14r)-14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl (2z)-2-methylbut-2-enoate
[(1s,3as,3br,7s,9ar,9bs,11ar)-7-(dimethylamino)-1-[(1s)-1-(dimethylamino)ethyl]-9a-methyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methanol
(2r)-pentan-2-yl 3-[(1s,2s,3r)-2-[2-(furan-3-yl)ethyl]-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoate
n-{1-[9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl}-n-methylacetamide
(5r)-1-methoxy-1-oxodecan-5-yl (3r,5r)-3,5-dihydroxydecanoate
(2s,4r,4as,4bs,8as,10ar)-2-ethenyl-10a-hydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 3-methylbut-2-enoate
16-isopropyl-1,5,9,13-tetramethyl-6-oxapentacyclo[10.7.0.0²,⁹.0⁵,⁷.0¹³,¹⁷]nonadec-17-ene-8,10-diol
(2e)-5-[3-hydroxy-5,8a-dimethyl-2-methylidene-5-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoic acid
(1r,3ar,5ar,6r,7s,9as,11ar)-7-hydroxy-1-[(2s)-1-hydroxypropan-2-yl]-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(1s,2r,6s,7s,8s,9s,11r,12s,15s)-15-isopropyl-1,8,12-trimethyl-5-methylidenetetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-16-ene-6,7,9-triol
(2s)-1-[(3s,3as,6s,7ar,10r,10ar,10bs)-3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl]-2,4-dihydroxy-4-methylpentan-3-one
3-{3,6,7a,10-tetramethyl-1h,2h,3h,4h,5h,6h,8h,9h,10ah,10bh-cyclopenta[d]s-indacen-10-yl}-1-(2-methyloxiran-2-yl)propane-1,2-diol
2-ethenyl-10a-hydroxy-2,4b,8,8-tetramethyl-decahydrophenanthren-4-yl 3-methylbut-2-enoate
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}ethanimidic acid
5-(furan-3-yl)-2-{[1-(hydroxymethyl)-1,4a-dimethyl-7-methylidene-octahydrobenzo[7]annulen-6-yl]methyl}pentan-1-ol
9-isopropyl-2,6,13,17-tetramethyl-18-oxapentacyclo[15.1.1.0²,¹⁴.0⁵,¹³.0⁶,¹⁰]nonadec-10-ene-3,19-diol
n-[(1s,3as,3bs,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]ethanimidic acid
(1s,4s,6r,9s,10s,13r,14s)-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl (2z)-2-methylbut-2-enoate
n-[(1s)-1-[(1s,3as,3br,5as,7s,9as,9bs,11as)-9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide
pentan-2-yl 3-{2-[2-(furan-3-yl)ethyl]-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl}propanoate
(2s)-2-amino-n,3-dihydroxy-n-(10-hydroxy-3-oxoheptadecyl)propanamide
C20H40N2O5 (388.29370700000004)